‘Fireside Chat’ on RNAi and CRISPR: What Can the Past Teach Us and What Opportunities Await?
45 minutes
Although researchers have been experimenting with gene therapy since the 1980s, 2018 was a major turning point in making these technologies a reality for patients. Not only was the first therapeutic using RNA interference (RNAi) approved last year, the first human clinical trials started for a CRISPR product. Come hear the two superstars of RNAi and CRISPR compare stories, lessons learned, thoughts on the future of gene editing, and more.
Tracks
| Name | Audience |
|---|---|
| Conference Wide |